Federal Capture Intelligence

Top HHS in-vitro diagnostic substance manufacturing contractors (NAICS 325413)

Contract actions: October 1, 2021 – September 10, 2026 Updated September 11, 2026 Department of Health and Human Services agency guide NAICS 325413 · In-Vitro Diagnostic Substance Manufacturing
Latest 12 months
$13.2M
Net obligations · Up $6.5M vs. $6.7M preceding
Prime contractors
62
With positive obligations in the latest 12 months

Research the HHS federal contracting market for in-vitro diagnostic substance manufacturing under NAICS 325413. Compare top federal contractors and market share, reported contract obligations and spending trends, funding-office attribution, recent award activity, contract types, competition, and procurement methods, and potential recompete research leads.

Contract obligation trends for In-Vitro Diagnostic Substance Manufacturing at the Department of Health and Human Services

Federal records show $1.3B in net obligations across 2,063 awards in In-Vitro Diagnostic Substance Manufacturing at the Department of Health and Human Services from Oct 1, 2021 through Sep 10, 2026. This market accounts for 0.91% of $145.5B in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations increased 97.6% from $6.7M to $13.2M. 19 prime contractors accounted for at least 80% of positive obligations in that latest period.

Fiscal-year activity

FY26 is year-to-date through Sep 10, 2026; earlier years show complete fiscal-year totals.

FY26 year-to-date: $11.6M versus $8.1M through the same date in FY25 (+42.0%).
Net obligations · complete fiscal yearNet obligations · FY26 YTDContract actions
View fiscal-year data table
Fiscal yearNet obligationsContract actionsCoverage
FY2022$89.0M744Complete
FY2023$1.2B759Complete
FY2024$30.0M688Complete
FY2025$9.8M565Complete
FY2026$11.6M324YTD through Sep 10, 2026

Market at a glance

All reported prime contract awards
All-period net obligations
$1.3B
2,063 awards · 281 prime contractors
Latest 12-month movement
+97.6%
$13.2M vs. $6.7M
Leading eight prime share
60.9%
Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
Agency context
0.91% of $145.5B in agency-wide net obligations.
Set-aside share when reported
5.4% of 1,516 awards with reported set-aside status.
Set-aside reporting
82 set aside · 1,434 no set-aside · 547 not reported

What changed in the last 12 months?

Sep 11, 2025–Sep 10, 2026, compared with Sep 11, 2024–Sep 10, 2025.

Competitive shifts

BIOTEKE USA, LLC had no reported activity in the latest 12 months
$2.1M→$0No latest-period activity
It previously ranked #3 by positive obligations, based on 3 reported actions.
10X GENOMICS, INC. lost the most market share
5.75%→3.31%−2.4 percentage points
The contractor now ranks #5 by positive obligations, based on 20 reported actions.

Buyer demand

Reported obligations through NATIONAL INSTITUTES OF HEALTH - CC decreased
$2.1M→$935K−$1.2M
Latest-period activity spans 30 awards across 22 prime contractors.
How these findings are calculated

Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.

Federal contract obligations by funding office

See how positive obligations were attributed across funding offices in the 12 months ending Sep 10, 2026.

31.8% of positive obligations were attributed to PHOENIX AREA INDIAN HEALTH SVC. That represents $4.4M, up $4.6M from the preceding 12 months.

Latest 12-month share of positive obligations; the gray segment represents all other reported offices.

  1. PHOENIX AREA INDIAN HEALTH SVC31.8% · $4.4M · up $4.6M
  2. FDA OFFICE OF ACQ GRANT SVCS15.6% · $2.2M · down $354K
  3. CDC OFFICE OF ACQUISITION SERVICES10.1% · $1.4M · down $97K
  4. NAVAJO AREA INDIAN HEALTH SVC9.6% · $1.3M · down $108K
  5. NATIONAL INSTITUTES OF HEALTH - CC6.7% · $935K · down $1.2M
  6. All other reported offices26.2% of positive obligations
View reported office rankings, comparisons, and evidence

USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.

  1. Reported funding office

    PHOENIX AREA INDIAN HEALTH SVC

    #1New to the positive-obligation ranking

    Latest 12 months

    $4.4M

    31.8% of positive obligations

    Versus preceding 12 months

    +$4.6M

    8 active prime contractors · 26 awards

    View office comparison and evidence

    Reported obligations moved from $224K in net deobligations to $4.4M in net obligations. The office’s share of positive obligations moved from 0% to 31.8%, a change of +31.8 percentage points.

    The latest period contains 28 actions across 26 awards. The preceding period contained 17 active prime contractors and 79 awards.

  2. Reported funding office

    FDA OFFICE OF ACQ GRANT SVCS

    #2Rank unchanged

    Latest 12 months

    $2.2M

    15.6% of positive obligations

    Versus preceding 12 months

    −$354K

    8 active prime contractors · 41 awards

    View office comparison and evidence

    Reported obligations decreased 14.1% from $2.5M to $2.2M. The office’s share of positive obligations moved from 14.0% to 15.6%, a change of +1.6 percentage points.

    The latest period contains 44 actions across 41 awards and 3 newly active prime contractors. The preceding period contained 5 active prime contractors and 26 awards.

  3. Reported funding office

    CDC OFFICE OF ACQUISITION SERVICES

    #3Up 2 from #5

    Latest 12 months

    $1.4M

    10.1% of positive obligations

    Versus preceding 12 months

    −$97K

    21 active prime contractors · 30 awards

    View office comparison and evidence

    Reported obligations decreased 6.5% from $1.5M to $1.4M. The office’s share of positive obligations moved from 8.3% to 10.1%, a change of +1.8 percentage points.

    The latest period contains 43 actions across 30 awards and 11 newly active prime contractors. The preceding period contained 19 active prime contractors and 27 awards.

  4. Reported funding office

    NAVAJO AREA INDIAN HEALTH SVC

    #4Up 2 from #6

    Latest 12 months

    $1.3M

    9.6% of positive obligations

    Versus preceding 12 months

    −$108K

    26 active prime contractors · 63 awards

    View office comparison and evidence

    Reported obligations decreased 7.5% from $1.4M to $1.3M. The office’s share of positive obligations moved from 8.0% to 9.6%, a change of +1.6 percentage points.

    The latest period contains 88 actions across 63 awards and 2 newly active prime contractors. The preceding period contained 30 active prime contractors and 73 awards.

  5. Reported funding office

    NATIONAL INSTITUTES OF HEALTH - CC

    #5Down 2 from #3

    Latest 12 months

    $935K

    6.7% of positive obligations

    Versus preceding 12 months

    −$1.2M

    22 active prime contractors · 30 awards

    View office comparison and evidence

    Reported obligations decreased 56.0% from $2.1M to $935K. The office’s share of positive obligations moved from 11.8% to 6.7%, a change of −5.1 percentage points.

    The latest period contains 32 actions across 30 awards and 4 newly active prime contractors. The preceding period contained 48 active prime contractors and 87 awards.

  6. Reported funding office

    ALBUQUERQUE AREA INDIAN HEALTH SVC

    #6Down 2 from #4

    Latest 12 months

    $905K

    6.5% of positive obligations

    Versus preceding 12 months

    −$633K

    6 active prime contractors · 19 awards

    View office comparison and evidence

    Reported obligations decreased 41.2% from $1.5M to $905K. The office’s share of positive obligations moved from 8.6% to 6.5%, a change of −2.0 percentage points.

    The latest period contains 32 actions across 19 awards. The preceding period contained 6 active prime contractors and 36 awards.

  7. Reported funding office

    NIH NCI

    #7Up 1 from #8

    Latest 12 months

    $432K

    3.1% of positive obligations

    Versus preceding 12 months

    −$88K

    7 active prime contractors · 9 awards

    View office comparison and evidence

    Reported obligations decreased 16.9% from $520K to $432K. The office’s share of positive obligations moved from 2.9% to 3.1%, a change of +0.2 percentage points.

    The latest period contains 9 actions across 9 awards and 5 newly active prime contractors. The preceding period contained 7 active prime contractors and 16 awards.

  8. Reported funding office

    NATIONAL INSTITUTES OF HEALTH OLAO

    #8Up 9 from #17

    Latest 12 months

    $366K

    2.6% of positive obligations

    Versus preceding 12 months

    +$312K

    10 active prime contractors · 13 awards

    View office comparison and evidence

    Reported obligations increased 587.1% from $53K to $366K. The office’s share of positive obligations moved from 0.30% to 2.6%, a change of +2.3 percentage points.

    The latest period contains 13 actions across 13 awards and 10 newly active prime contractors. The preceding period contained 3 active prime contractors and 4 awards.

  9. Reported funding office

    NATIONAL INSTITUTES OF HEALTH NIA

    #9Down 2 from #7

    Latest 12 months

    $351K

    2.5% of positive obligations

    Versus preceding 12 months

    −$255K

    8 active prime contractors · 10 awards

    View office comparison and evidence

    Reported obligations decreased 42.1% from $606K to $351K. The office’s share of positive obligations moved from 3.4% to 2.5%, a change of −0.8 percentage points.

    The latest period contains 11 actions across 10 awards and 7 newly active prime contractors. The preceding period contained 6 active prime contractors and 8 awards.

  10. Reported funding office

    BARDA - ASPR / DAAPPO / BARDA DCMA

    #10New to the positive-obligation ranking

    Latest 12 months

    $335K

    2.4% of positive obligations

    Versus preceding 12 months

    +$7.3M

    2 active prime contractors · 2 awards

    View office comparison and evidence

    Reported obligations moved from $7.0M in net deobligations to $335K in net obligations. The office’s share of positive obligations moved from 0% to 2.4%, a change of +2.4 percentage points.

    The latest period contains 7 actions across 2 awards. The preceding period contained 5 active prime contractors and 5 awards.

    Leading award-level changes

  11. Reported funding office

    OFC ASST SEC FOR PREPARENESS RES

    No positive-obligation rank

    Latest 12 months

    $0

    0% of positive obligations

    Versus preceding 12 months

    +$2.4M

    0 active prime contractors · 0 awards

    View office comparison and evidence

    Reported obligations moved from $2.4M in net deobligations to $0 in net obligations. The office’s share of positive obligations moved from 0% to 0%, a change of 0.0 percentage points.

    The latest period contains 0 actions across 0 awards. The preceding period contained 8 active prime contractors and 8 awards.

  12. Reported funding office

    ASPR/DAAPPO/ORM HQ

    No positive-obligation rank

    Latest 12 months

    $0

    0% of positive obligations

    Versus preceding 12 months

    +$1.6M

    0 active prime contractors · 0 awards

    View office comparison and evidence

    Reported obligations moved from $1.6M in net deobligations to $0 in net obligations. The office’s share of positive obligations moved from 0% to 0%, a change of 0.0 percentage points.

    The latest period contains 0 actions across 0 awards. The preceding period contained 5 active prime contractors and 5 awards.

  13. Reported funding office

    INDUSTRIAL BASED MANUFACTURING AND SUPPLY CHAIN (IBMSC)

    No positive-obligation rank

    Latest 12 months

    $0

    0% of positive obligations

    Versus preceding 12 months

    −$6.2M

    0 active prime contractors · 0 awards

    View office comparison and evidence

    Reported obligations decreased 100.0% from $6.2M to $0. The office’s share of positive obligations moved from 34.5% to 0%, a change of −34.5 percentage points.

    The latest period contains 0 actions across 0 awards. The preceding period contained 4 active prime contractors and 5 awards.

    Leading award-level changes

  14. Reported funding office

    INDIAN HEALTH SERVICE

    No positive-obligation rank

    Latest 12 months

    −$379K

    0% of positive obligations

    Versus preceding 12 months

    −$379K

    2 active prime contractors · 2 awards

    View office comparison and evidence

    Reported obligations widened from $81 to $379K in net deobligations. The office’s share of positive obligations moved from 0% to 0%, a change of 0.0 percentage points.

    The latest period contains 2 actions across 2 awards and 2 newly active prime contractors. The preceding period contained 1 active prime contractor and 1 award.

Contract types, competition, and procurement methods

From Sep 11, 2025 through Sep 10, 2026, 162 awards had positive obligations totaling $17.5M. Simplified Acquisition was the leading reported procedure, accounting for 48.0% of positive obligations. Awards with a reported parent IDV accounted for 60.7%.

Leading award type
39.3%
Purchase Order
Leading reported procedure
48.0%
Simplified Acquisition
Reported parent IDV
60.7%
of positive obligations had a reported parent IDV
Median reported offers
1
131 of 162 awards reported offers

Buying method changes

Compared with Sep 11, 2024–Sep 10, 2025. Based on 162 current awards and 281 preceding awards with positive net obligations.

Median positive award obligations
$49K
Up from $25K in the preceding period
Simplified Acquisition obligation share
48.0%
Down from 60.3% in the preceding period
How to read these changes

Directional color and the Up or Down labels show historical movement only. Green does not mean favorable and red does not mean unfavorable; neither predicts a future procurement method.

Same-NAICS comparison

Compared with the NAICS 325413 peer median, parent-IDV obligation share is 17.2 percentage points lower, reported full-and-open obligation share is 6.7 percentage points higher, delivery-order obligation share is 18.5 percentage points lower, and median positive award obligations are 19.3% higher.

MeasureThis marketPeer medianDifference
Parent-IDV obligation share60.7%77.9%-17.2 pts
Reported full-and-open obligation share16.5%9.8%+6.7 pts
Delivery-order obligation share24.9%43.4%-18.5 pts
Median positive award obligations$49K$41K+19.3%
Peer cohort and comparison limits

The peer median gives each of the 3 eligible agency markets equal weight. The included agency markets are:

Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.

View buying-method details and data coverage

Award types

Reported valueAwardsPositive obligationsShare
Purchase Order(B)91$6.9M39.3%
BPA Call(A)33$6.3M35.9%
Delivery Order(C)38$4.3M24.9%

Reported parent-award types

Reported valueAwardsPositive obligationsShare
BPA(E)33$6.3M35.9%
IDC(B)26$2.6M15.0%
FSS(C)12$1.7M9.8%
Not reported91$6.9M39.3%

Single- or multiple-award parent structure

Reported valueAwardsPositive obligationsShare
Single Award(S)59$8.9M50.9%
Multiple Award(M)12$1.7M9.8%
Not reported91$6.9M39.3%

Solicitation procedures

Reported valueAwardsPositive obligationsShare
Simplified Acquisition(SP1)79$8.4M48.0%
Subject to Multiple Award Fair Opportunity(MAFO)13$2.8M16.1%
Sp1(SIMPLIFIED ACQUISITION)25$2.5M14.3%
Only One Source(SSS)33$2.3M13.0%
Sss(ONLY ONE SOURCE)7$867K5.0%
Mafo(SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY)4$565K3.2%
Other reported values1$68K0.39%

Extent competed

Reported valueAwardsPositive obligationsShare
Competed Under SAP(F)45$5.9M33.7%
Full and Open Competition(A)14$2.9M16.5%
Not Competed Under SAP(G)34$2.5M14.3%
Not Competed(C)33$2.3M13.0%
F(COMPETED UNDER SAP)14$1.4M7.8%
G(NOT COMPETED UNDER SAP)11$1.1M6.5%
Other reported values11$1.4M8.2%

Fair-opportunity and limited-source reporting

Reported valueAwardsPositive obligationsShare
Only One Source - Other(ONE)13$2.9M16.5%
Fair Opportunity Given(FAIR)4$491K2.8%
Not reported145$14.1M80.7%

Other-than-full-and-open reasons

Reported valueAwardsPositive obligationsShare
SAP Non-Competition (FAR 13)(SP2)40$3.4M19.3%
Only One Source-Other (FAR 6.302-1 Other)(ONE)38$2.9M16.7%
Authorized by Statute (FAR 6.302-5(A)(2)(I))(OTH)5$261K1.5%
Unique Source (FAR 6.302-1(B)(1))(UNQ)1$138K0.79%
Urgency (FAR 6.302-2)(URG)1$84K0.48%
Not reported77$10.7M61.2%

Contract pricing types

Reported valueAwardsPositive obligationsShare
Firm Fixed Price(J)126$13.5M77.5%
J(FIRM FIXED PRICE)36$3.9M22.5%

Product or Service Codes

Reported valueAwardsPositive obligationsShare
in Vitro Diagnostic Substances, Reagents, Test Kits and Sets(6550)71$9.0M51.4%
Medical and Surgical Instruments, Equipment, and Supplies(6515)11$3.9M22.3%
Laboratory Equipment and Supplies(6640)45$3.0M16.9%
Drugs and Biologicals(6505)11$785K4.5%
Maint/Repair/Rebuild of Equipment- Instruments and Laboratory Equipment(J066)11$280K1.6%
Lease or Rental of Equipment- Instruments and Laboratory Equipment(W066)1$122K0.70%
Other reported values12$453K2.6%

Awarding subagencies

Reported valueAwardsPositive obligationsShare
Indian Health Service(7527)54$9.7M55.6%
National Institutes of Health(7529)62$3.7M21.4%
Food and Drug Administration(7524)26$2.2M12.5%
Centers for Disease Control and Prevention(7523)19$1.5M8.6%
Office of Assistant Secretary for Preparedness and Response(7505)1$335K1.9%

Awarding offices

Reported valueAwardsPositive obligationsShare
Phoenix Area Indian Health Svc(75H712)17$5.9M33.9%
Navajo Area Indian Health Svc(75H710)24$2.2M12.8%
Fda Office of Acq Grant Svcs(75F401)26$2.2M12.5%
National Institutes of Health Olao(75N980)30$1.6M9.4%
Cdc Office of Acquisition Services(75D301)19$1.5M8.6%
Albuquerque Area Indian Health Svc(75H707)8$1.4M8.2%
Other reported values38$2.6M14.6%

Reported parent IDVs

Reported valueAwardsPositive obligationsShare
75H71223A00001(7527)6$3.2M18.6%
75F40123D00001(7524)18$1.7M9.8%
75H71224A00007(7527)3$1.3M7.6%
36F79718D0395(3600)2$671K3.8%
36F79724D0020(3600)1$457K2.6%
75H71221A00002(7527)1$400K2.3%
75N98022A00032(7529)15$343K2.0%
75F40122D00010(7524)5$309K1.8%
Other reported values20$2.2M12.3%
Not reported91$6.9M39.3%

Offers, award size, and timing

Median reported offers
1 median
131 reported · 31 not reported
Positive award obligations
$49K median
$22K–$125K middle 50%
Reported performance period
364 days (~12 months) median
162 reported · 0 not reported

Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Sep 10, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.

Top federal contractors

Latest 12-month market share, concentration, and complete prime contractor rankings across the period shown.

Prime contractor concentration
19 of 62prime contractors account for at least 80% of positive obligations in the last 12 months
Largest prime contractor
26.9%of positive obligations in the last 12 months
Leading four prime contractors
50.1%of positive obligations in the last 12 months
Leading eight prime contractors
60.9%of positive obligations in the last 12 months

Based on $14.4M in positive obligations during the 12 months ending Sep 10, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Sep 11, 2024–Sep 10, 2025.

Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.

15 leading contractors
  1. #1

    Last 12mo obligations

    $3.9M

    26.9%

    Dollar movement

    +$113K

    vs. prior 12 months

    Last 12mo awards

    20 awards

    29 actions

    Historical and award details for CEPHEID
    Obligations: prior → latest
    $3.8M → $3.9M
    +3.0%
    Share: prior → latest
    19.0% → 26.9%
    +7.8 percentage points
    All-period obligations
    $18.9M
    1.4% of all-period positive obligations · 76 awards
    Recorded activity
    Since Dec 6, 2021
    through Sep 9, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside2028
    Not reported07
    Reported small business00
    All-period set-aside types

    None reported.

  2. #2

    Last 12mo obligations

    $1.8M

    12.6%

    Dollar movement

    −$339K

    vs. prior 12 months

    Last 12mo awards

    30 awards

    32 actions

    Historical and award details for ILLUMINA, INC.
    Obligations: prior → latest
    $2.2M → $1.8M
    −15.7%
    Share: prior → latest
    10.9% → 12.6%
    +1.7 percentage points
    All-period obligations
    $12.0M
    0.90% of all-period positive obligations · 129 awards
    Recorded activity
    Since Mar 25, 2022
    through Aug 25, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside45
    Not reported2616
    Reported small business00
    All-period set-aside types

    None reported.

  3. #3

    Last 12mo obligations

    $976K

    6.8%

    Dollar movement

    −$347K

    vs. prior 12 months

    Last 12mo awards

    16 awards

    18 actions

    Historical and award details for BIOMERIEUX INC
    Obligations: prior → latest
    $1.3M → $976K
    −26.2%
    Share: prior → latest
    6.7% → 6.8%
    +0.1 percentage points
    All-period obligations
    $4.4M
    0.33% of all-period positive obligations · 58 awards
    Recorded activity
    Since Oct 26, 2021
    through Jul 21, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside97
    Not reported79
    Reported small business00
    All-period set-aside types

    None reported.

  4. #4

    Last 12mo obligations

    $563K

    3.9%

    Dollar movement

    +$153K

    vs. prior 12 months

    Last 12mo awards

    11 awards

    15 actions

    Historical and award details for WERFEN USA LLC
    Obligations: prior → latest
    $410K → $563K
    +37.3%
    Share: prior → latest
    2.1% → 3.9%
    +1.8 percentage points
    All-period obligations
    $1.2M
    0.090% of all-period positive obligations · 31 awards
    Recorded activity
    Since May 15, 2023
    through Sep 9, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside23
    Not reported914
    Reported small business00
    All-period set-aside types

    None reported.

  5. #5

    Last 12mo obligations

    $478K

    3.3%

    Dollar movement

    −$661K

    vs. prior 12 months

    Last 12mo awards

    20 awards

    20 actions

    Historical and award details for 10X GENOMICS, INC.
    Obligations: prior → latest
    $1.1M → $478K
    −58.0%
    Share: prior → latest
    5.8% → 3.3%
    −2.4 percentage points
    All-period obligations
    $6.7M
    0.50% of all-period positive obligations · 262 awards
    Recorded activity
    Since Dec 30, 2021
    through Sep 8, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside2050
    Not reported00
    Reported small business13
    All-period set-aside types
    • 22 · Total small business
  6. #6

    Last 12mo obligations

    $383K

    2.6%

    Dollar movement

    +$34K

    vs. prior 12 months

    Last 12mo awards

    9 awards

    13 actions

    Historical and award details for REMEL INC.
    Obligations: prior → latest
    $349K → $383K
    +9.6%
    Share: prior → latest
    1.8% → 2.6%
    +0.9 percentage points
    All-period obligations
    $1.9M
    0.14% of all-period positive obligations · 55 awards
    Recorded activity
    Since Nov 30, 2021
    through Sep 2, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside34
    Not reported65
    Reported small business01
    All-period set-aside types

    None reported.

  7. #7

    Last 12mo obligations

    $357K

    2.5%

    Dollar movement

    +$357K

    vs. prior 12 months

    Last 12mo awards

    1 award

    1 action

    Historical and award details for BEACON SCIENTIFIC INC
    Obligations: prior → latest
    $0 → $357K
    Not comparable
    Share: prior → latest
    0% → 2.5%
    +2.5 percentage points
    All-period obligations
    $357K
    0.030% of all-period positive obligations · 1 award
    Recorded activity
    Since Sep 2, 2026
    through Sep 2, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside10
    Not reported00
    Reported small business10
    All-period set-aside types

    None reported.

  8. #8

    Last 12mo obligations

    $340K

    2.4%

    Dollar movement

    −$382K

    vs. prior 12 months

    Last 12mo awards

    4 awards

    5 actions

    Historical and award details for ROCHE DIABETES CARE INC
    Obligations: prior → latest
    $722K → $340K
    −52.9%
    Share: prior → latest
    3.6% → 2.4%
    −1.3 percentage points
    All-period obligations
    $2.3M
    0.17% of all-period positive obligations · 22 awards
    Recorded activity
    Since Nov 29, 2021
    through Aug 28, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported45
    Reported small business00
    All-period set-aside types

    None reported.

  9. #9

    Last 12mo obligations

    $335K

    2.3%

    Dollar movement

    −$143K

    vs. prior 12 months

    Last 12mo awards

    1 award

    4 actions

    Historical and award details for ORASURE TECHNOLOGIES INC
    Obligations: prior → latest
    $477K → $335K
    −29.9%
    Share: prior → latest
    2.4% → 2.3%
    −0.1 percentage points
    All-period obligations
    $685K
    0.050% of all-period positive obligations · 6 awards
    Recorded activity
    Since Feb 28, 2022
    through Aug 17, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside12
    Not reported00
    Reported small business12
    All-period set-aside types
    • 1 · Total small business
  10. #10

    Last 12mo obligations

    $308K

    2.1%

    Dollar movement

    +$215K

    vs. prior 12 months

    Last 12mo awards

    2 awards

    11 actions

    Historical and award details for MCKESSON MEDICAL-SURGICAL GOVERNMENT SOLUTIONS LLC
    Obligations: prior → latest
    $93K → $308K
    +230.6%
    Share: prior → latest
    0.47% → 2.1%
    +1.7 percentage points
    All-period obligations
    $704K
    0.050% of all-period positive obligations · 3 awards
    Recorded activity
    Since May 1, 2023
    through Sep 8, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside23
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  11. #11

    Last 12mo obligations

    $288K

    2.0%

    Dollar movement

    +$331K

    vs. prior 12 months

    Last 12mo awards

    18 awards

    20 actions

    Historical and award details for FISHER SCIENTIFIC COMPANY L.L.C.
    Obligations: prior → latest
    −$44K → $288K
    Not comparable
    Share: prior → latest
    0% → 2.0%
    +2.0 percentage points
    All-period obligations
    $3.4M
    0.25% of all-period positive obligations · 114 awards
    Recorded activity
    Since Nov 10, 2021
    through Jul 7, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside64
    Not reported1236
    Reported small business00
    All-period set-aside types

    None reported.

  12. #12

    Last 12mo obligations

    $272K

    1.9%

    Dollar movement

    +$234K

    vs. prior 12 months

    Last 12mo awards

    2 awards

    2 actions

    Historical and award details for GOVERNMENT SCIENTIFIC SOURCE INC
    Obligations: prior → latest
    $38K → $272K
    +615.2%
    Share: prior → latest
    0.19% → 1.9%
    +1.7 percentage points
    All-period obligations
    $732K
    0.050% of all-period positive obligations · 17 awards
    Recorded activity
    Since Oct 26, 2021
    through Sep 22, 2025

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside10
    Reported no set-aside11
    Not reported00
    Reported small business21
    All-period set-aside types
    • 7 · Total small business
  13. #13

    Last 12mo obligations

    $250K

    1.7%

    Dollar movement

    −$283K

    vs. prior 12 months

    Last 12mo awards

    15 awards

    15 actions

    Historical and award details for ROCHE DIAGNOSTICS CORPORATION
    Obligations: prior → latest
    $533K → $250K
    −53.1%
    Share: prior → latest
    2.7% → 1.7%
    −1.0 percentage points
    All-period obligations
    $94.0M
    7.0% of all-period positive obligations · 96 awards
    Recorded activity
    Since Oct 20, 2021
    through Aug 25, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside55
    Not reported1015
    Reported small business00
    All-period set-aside types

    None reported.

  14. #14

    Last 12mo obligations

    $249K

    1.7%

    Dollar movement

    −$51K

    vs. prior 12 months

    Last 12mo awards

    2 awards

    5 actions

    Historical and award details for RED HERITAGE MEDICAL LLC
    Obligations: prior → latest
    $300K → $249K
    −17.0%
    Share: prior → latest
    1.5% → 1.7%
    +0.2 percentage points
    All-period obligations
    $905K
    0.070% of all-period positive obligations · 6 awards
    Recorded activity
    Since Feb 1, 2022
    through Aug 28, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside11
    Reported no set-aside10
    Not reported00
    Reported small business21
    All-period set-aside types
    • 3 · Indian small business
    • 1 · BUY INDIAN
  15. #15

    Last 12mo obligations

    $249K

    1.7%

    Dollar movement

    +$249K

    vs. prior 12 months

    Last 12mo awards

    1 award

    1 action

    Historical and award details for SPEED BIOSYSTEMS, LLC
    Obligations: prior → latest
    $0 → $249K
    Not comparable
    Share: prior → latest
    0% → 1.7%
    +1.7 percentage points
    All-period obligations
    $933K
    0.070% of all-period positive obligations · 5 awards
    Recorded activity
    Since Jan 19, 2022
    through Sep 25, 2025

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside10
    Not reported00
    Reported small business10
    All-period set-aside types

    None reported.

Potential federal contract recompetes

Investigate potential recompetes surfaced by near-term end dates, award value, and recent contract changes.

SIRO DIAGNOSTICS, INC.

ADVANCED DEVELOPMENT OF A NAAT MULTIPLEX RESPIRATORY PATHOGEN TEST FOR PROFESSIONAL POINT-OF- CARE (CLIA WAIVED) AND AT-HOME OTC USE WITH THE CUE HEALTH MONITORING SYSTEM (READER) AND CUE SAMPLE WAND

The reported potential end date moved later 3 times in the latest 12 months.

Performance period

98.3%

As of Sep 10, 2026Potential end Sep 30, 2026

Current award value as a share of potential value

99.7%

$28.3M current$28.4M potential
Supporting data

Reported performance starts Aug 2, 2023.

No later potential end date is reported; current and potential end dates are both Sep 30, 2026.

$28.3M is obligated against $28.3M in current reported award value (100.0%).

Reported potential end dates: Dec 31, 2025 → Mar 31, 2026 → Jun 30, 2026 → Sep 30, 2026.

Obligations are compared with current reported award value, not treated as a contract ceiling.

PIID 75A50123C00036

These are research leads, not confirmed recompetes. USAspending records through Sep 10, 2026; reported dates and values can change through later modifications.

Recent federal contract award activity

Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.

Base award

This action

+$1.8M

CEPHEID

PHOENIX AREA INDIAN HEALTH SVC

NEW BPA CALL FOR CEPHEID SUPPLIES

Why it stands out

One action represented 12.5% of the market’s latest 12-month positive obligations.

At $1.8M, the action was large enough to materially affect the latest 12-month market picture.

Award net obligations
$1.8M
Share of 12-month positive obligations
12.5%
Supporting data
Funding office
#1 · 31.8% attributed share
+31.8 percentage points · $4.6M net increase; action accounted for 38.8%
PIID 75H71226F28028
Deobligation

This action

−$943K

CEPHEID

ALBUQUERQUE AREA INDIAN HEALTH SVC

MODIFICATION P00012 TO DE-OBLIGATE EXCESS FUNDS.

Why it stands out

The award contracted while the contractor grew overall.

The action removed $943K while the contractor rose $113K.

Award net obligations
$2.8M
Share of 12-month positive obligations
6.5%
Supporting data
Prime contractor
#1 · 26.9% share
$113K net increase despite this negative action
Funding office
#6 · 6.5% attributed share
down 2 ranks · −2.0 percentage points · $633K net decline; action exceeded it by $310K
PIID 75H70722P00094 · Mod P00012
Base award

This action

+$1.2M

BIOMERIEUX INC

PHOENIX AREA INDIAN HEALTH SVC

BPA, BIOMERIEUX, BIOFIRE PANEL REAGENTS, PIMC LABORATORY DEPT, BPA CALL 26F28007

Why it stands out

A new award added obligations despite weaker contractor activity.

The action represented 8.4% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $347K overall.

Award net obligations
$1.2M
Share of 12-month positive obligations
8.4%
Supporting data
Prime contractor
#3 · 6.8% share
$347K net decline despite this positive action
PIID 75H71226F28007
Deobligation

This action

−$403K

ABBOTT RAPID DX NORTH AMERICA LLC

INDIAN HEALTH SERVICE

DEOB AND CLOSE: AGENCY WIDE IDIQ CONTRACT TO PROVIDE LABORATORY ANALYZERS, TESTING KITS/REAGENTS, ASSOCIATED PERIPHERALS, AND THE ASSOCIATED SUPPORT AND SERVICE AGREEMENTS IN ORDER TO EFFECTIVELY TEST FOR COVID-19 SPECIMENS, AND OTHER SAMPLES AND CUL

Why it stands out

This award recorded a material contraction.

The action removed $403K. A deobligation does not by itself show lower requirement demand.

Award net obligations
$55.1M
Share of 12-month positive obligations
2.8%
Supporting data
Funding office
0% attributed share
$379K net decline; action exceeded it by $24K
PIID 75H71122P00945 · Mod P00002
Base award

This action

+$357K

BEACON SCIENTIFIC INC

CDC OFFICE OF ACQUISITION SERVICES

PROCUREMENT OF LATERAL FLOW CASSETTES FOR THE RAPID HIV NUCLEIC ACID DIAGNOSTIC TEST-EO 14893

Why it stands out

No activity for this contractor was reported in this market during the preceding 12 months.

The base action placed the contractor #7 in this market by positive obligations over the latest 12 months.

Award net obligations
$357K
Share of 12-month positive obligations
2.5%
Supporting data
Prime contractor
#7 · 2.5% share
Newly active in this market; no actions were reported in the preceding 12 months
Funding office
#3 · 10.1% attributed share
$97K net decline despite this positive action
PIID 75D30126P21454
Deobligation

This action

−$345K

BIOFIRE DIAGNOSTICS LLC

NATIONAL INSTITUTES OF HEALTH - CC

TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS.

Why it stands out

The award contracted while the contractor grew overall.

The action removed $345K while the contractor rose $1.2M.

Award net obligations
$1.3M
Share of 12-month positive obligations
2.4%
Supporting data
Prime contractor
0% share
$1.2M net increase despite this negative action
Funding office
#5 · 6.7% attributed share
down 2 ranks · −5.1 percentage points · $1.2M net decline; action accounted for 29.0%
Related:Funding office decline
PIID HHSN269201700022U · Mod P00007
View recent award activity by date (10)
  1. CEPHEIDBase award · PIID 75H70726P00144
    Action+$136K
    Award net obligations$136K
  2. WERFEN USA LLCModification · PIID 75H71025F80231
    Action+$53K
    Award net obligations$122K
  3. MILECELL BIOTECHNOLOGY INC.Base award · PIID 75F40126P00211
    Action+$25K
    Award net obligations$25K
  4. CEPHEIDBase award · PIID 75H71026P00305
    Action+$175K
    Award net obligations$175K
  5. MCKESSON MEDICAL-SURGICAL GOVERNMENT SOLUTIONS LLCModification · PIID 75H71025P00182
    Action+$80K
    Award net obligations$240K
  6. 10X GENOMICS, INC.Base award · PIID 75N98026F90026
    Action+$37K
    Award net obligations$37K
  7. WERFEN USA LLCBase award · PIID 75H71026F80076
    Action+$108K
    Award net obligations$108K
  8. BEACON SCIENTIFIC INCBase award · PIID 75D30126P21454
    Action+$357K
    Award net obligations$357K
  9. CEPHEIDDeobligation · PIID 75H70722P00232
    Action−$157K
    Award net obligations$600K
  10. REMEL INC.Base award · PIID 75F40126F19021
    Action+$110K
    Award net obligations$110K

HHS in-vitro diagnostic substance manufacturing market FAQs

Answers based on reported federal contract data.

Who are the top HHS in-vitro diagnostic substance manufacturing contractors?

In the 12 months through September 10, 2026, CEPHEID, ILLUMINA, INC., and BIOMERIEUX INC were the leading HHS in-vitro diagnostic substance manufacturing prime contractors by positive obligations.

  1. #1

    CEPHEID

    $3,881,038 in positive obligations

  2. #2

    ILLUMINA, INC.

    $1,817,111 in positive obligations

  3. #3

    BIOMERIEUX INC

    $976,076 in positive obligations

Rankings use reported USAspending award data.

Did HHS contract obligations increase in the in-vitro diagnostic substance manufacturing market?

Yes. Measured by net prime contract obligations, reported HHS activity in the in-vitro diagnostic substance manufacturing market increased 97.6% from $6,696,288 in the preceding 12 months to $13,234,393 in the 12 months through September 10, 2026.

Latest 12 months
$13,234,393
Net prime contract obligations
Preceding 12 months
$6,696,288
Net prime contract obligations
Change
+97.6%
Between matched 12-month periods

Reported contract actions, not outlays or a forecast.

What recent HHS contract award activity was reported in the in-vitro diagnostic substance manufacturing market?

Recent HHS contract award activity reported in the in-vitro diagnostic substance manufacturing market included actions for CEPHEID, BIOMERIEUX INC, and ABBOTT RAPID DX NORTH AMERICA LLC during the 12 months through September 10, 2026.

Action obligations are transaction-level amounts, not current award-level obligations.

Which procurement methods were reported for HHS contracts under NAICS 325413?

From September 11, 2025 through September 10, 2026, HHS reported 162 positive-obligation awards for in-vitro diagnostic substance manufacturing under NAICS 325413. The leading award type was purchase order. The leading reported procedure was simplified acquisition.

Positive-obligation awards
162
Leading reported procedure
Simplified Acquisition
48% of positive obligations
Leading award type
Purchase Order
39.3% of positive obligations
Full and open
16.5%
of positive obligations
Reported parent IDV
60.7%
of positive obligations

Percentages use positive obligations as the denominator.

Which HHS in-vitro diagnostic substance manufacturing awards may warrant recompete research?

Based on its reported potential-end date, the HHS in-vitro diagnostic substance manufacturing award held by SIRO DIAGNOSTICS, INC. may warrant recompete research.

Research leads, not confirmed recompetes. Dates may change through later modifications.

Apply this research to a live pursuit

Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.

See Sweetspot in action

Related market research

Complete market indexes:

Same NAICS at other agencies:

Nearby NAICS at this agency:

Markets sharing leading prime records:

Leading-prime vehicle memberships:

Company memberships do not establish award-channel use.

Reported obligations include contract actions from October 1, 2021 through September 10, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility.

Review data methodology